| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sita Sharan Patel, Vineet Mehta, Harish Changotra, Malairaman Udayaban. Depression mediates impaired glucose tolerance and cognitive dysfunction: A neuromodulatory role of rosiglitazone. Hormones and behavior. vol 78. 2016-09-15. PMID:26631485. |
rosiglitazone (rosi) ameliorate cognitive deficit associated with depression and insulin resistance. |
2016-09-15 |
2023-08-13 |
mouse |
| Jenise C Wong, Lawrence M Dolan, Tony T Yang, Korey K Hoo. Insulin pump use and glycemic control in adolescents with type 1 diabetes: Predictors of change in method of insulin delivery across two years. Pediatric diabetes. vol 16. issue 8. 2016-09-02. PMID:25387433. |
few studies have explored durability of insulin pump use, and none have explored the link between depression and pump discontinuation. |
2016-09-02 |
2023-08-13 |
Not clear |
| Jenise C Wong, Lawrence M Dolan, Tony T Yang, Korey K Hoo. Insulin pump use and glycemic control in adolescents with type 1 diabetes: Predictors of change in method of insulin delivery across two years. Pediatric diabetes. vol 16. issue 8. 2016-09-02. PMID:25387433. |
to examine the relationship between depressive symptoms [measured by the children's depression inventory (cdi)], method of insulin delivery, and hemoglobin a1c (a1c), mixed models were used with data from 150 adolescents with type 1 diabetes (t1d) and visits every 6 months for 2 years. |
2016-09-02 |
2023-08-13 |
Not clear |
| Donatella Marazziti, Grazia Rutigliano, Stefano Baroni, Paola Landi, Liliana Dell'Oss. Metabolic syndrome and major depression. CNS spectrums. vol 19. issue 4. 2016-08-08. PMID:24103843. |
epidemiological studies have consistently demonstrated a co-occurrence of depression with mes components, ie, visceral obesity, dyslipidemia, insulin resistance, and hypertension. |
2016-08-08 |
2023-08-12 |
Not clear |
| Alexander Schäfer, Susanne Neschen, Melanie Kahle, Hakan Sarioglu, Tobias Gaisbauer, Axel Imhof, Jerzy Adamski, Stefanie M Hauck, Marius Ueffin. The Epoxyeicosatrienoic Acid Pathway Enhances Hepatic Insulin Signaling and is Repressed in Insulin-Resistant Mouse Liver. Molecular & cellular proteomics : MCP. vol 14. issue 10. 2016-07-28. PMID:26070664. |
the stimulation of insulin signaling by eets and depression of the pathway in insulin resistant liver suggest a likely role in hepatic insulin resistance. |
2016-07-28 |
2023-08-13 |
mouse |
| Kathleen Watson Lin, Tonita E Wroolie, Thalia Robakis, Natalie L Rasgo. Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response. Psychiatry research. vol 230. issue 3. 2016-07-26. PMID:26602230. |
previous studies suggest that insulin-sensitizing agents could play a significant role in the treatment of major depression, particularly depression in patients with documented insulin resistance or those who are resistant to standard psychopharmacological approaches. |
2016-07-26 |
2023-08-13 |
Not clear |
| Kathleen Watson Lin, Tonita E Wroolie, Thalia Robakis, Natalie L Rasgo. Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response. Psychiatry research. vol 230. issue 3. 2016-07-26. PMID:26602230. |
patients (n=37) with non-psychotic, non-remitting depression receiving standard psychiatric regimens for depression were randomized across an insulin sensitivity spectrum in a 12-week double blind, randomized controlled trial of pioglitazone or placebo. |
2016-07-26 |
2023-08-13 |
Not clear |
| Kathleen Watson Lin, Tonita E Wroolie, Thalia Robakis, Natalie L Rasgo. Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response. Psychiatry research. vol 230. issue 3. 2016-07-26. PMID:26602230. |
improvement in depression was associated with improvement in glucose metabolism but only in patients with insulin resistance. |
2016-07-26 |
2023-08-13 |
Not clear |
| Hamidreza Roohafza, Pedram Shokouh, Masoumeh Sadeghi, Zahra Alikhassy, Nizal Sarrafzadega. A Possible Role for Pioglitazone in the Management of Depressive Symptoms in Metabolic Syndrome Patients (EPICAMP Study): A Double Blind, Randomized Clinical Trial. International scholarly research notices. vol 2014. 2016-07-19. PMID:27433505. |
with respect to our findings, alterations in depression severity were not correlated with changes in insulin resistance level (p = 0.145). |
2016-07-19 |
2023-08-13 |
human |
| Zahra Sepehrmanesh, Fariba Kolahdooz, Fatemeh Abedi, Navid Mazroii, Amin Assarian, Zatollah Asemi, Ahmad Esmaillzade. Vitamin D Supplementation Affects the Beck Depression Inventory, Insulin Resistance, and Biomarkers of Oxidative Stress in Patients with Major Depressive Disorder: A Randomized, Controlled Clinical Trial. The Journal of nutrition. vol 146. issue 2. 2016-06-09. PMID:26609167. |
vitamin d supplementation affects the beck depression inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized, controlled clinical trial. |
2016-06-09 |
2023-08-13 |
Not clear |
| M M Iversen, G Nefs, G S Tell, B Espehaug, K Midthjell, M Graue, F Pouwe. Anxiety, depression and timing of insulin treatment among people with type 2 diabetes: Nine-year follow-up of the Nord-Trøndelag Health Study, Norway. Journal of psychosomatic research. vol 79. issue 4. 2016-04-28. PMID:26208403. |
anxiety, depression and timing of insulin treatment among people with type 2 diabetes: nine-year follow-up of the nord-trøndelag health study, norway. |
2016-04-28 |
2023-08-13 |
Not clear |
| Alice P S Kong, Juliana C N Cha. Hypoglycemia and Comorbidities in Type 2 Diabetes. Current diabetes reports. vol 15. issue 10. 2016-04-28. PMID:26338288. |
risk factors associated with hypoglycemia in patients with type 2 diabetes include old age, long disease duration, low body mass index, high baseline glycated hemoglobin (hba1c), treatment with insulin and sulphonylurea, renal dysfunction, albuminuria, reduced level of low density lipoprotein cholesterol, low triglyceride and depression. |
2016-04-28 |
2023-08-13 |
Not clear |
| Erikka Loftfield, Neal D Freedman, Barry I Graubard, Kristin A Guertin, Amanda Black, Wen-Yi Huang, Fatma M Shebl, Susan T Mayne, Rashmi Sinh. Association of Coffee Consumption With Overall and Cause-Specific Mortality in a Large US Prospective Cohort Study. American journal of epidemiology. vol 182. issue 12. 2016-04-05. PMID:26614599. |
coffee may reduce mortality risk by favorably affecting inflammation, lung function, insulin sensitivity, and depression. |
2016-04-05 |
2023-08-13 |
Not clear |
| Rosita Dangman. An insulin based model to explain changes and interactions in human breath-holding. Medical hypotheses. vol 84. issue 6. 2016-03-28. PMID:25801485. |
the depression of insulin secretion through the vagus nerve activation via inspiration is discussed. |
2016-03-28 |
2023-08-13 |
human |
| Katherine Semenkovich, Miriam E Brown, Dragan M Svrakic, Patrick J Lustma. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. vol 75. issue 6. 2016-02-29. PMID:25851098. |
depression increases the risk of the development of t2dm and the subsequent risks of hyperglycemia, insulin resistance, and micro- and macrovascular complications. |
2016-02-29 |
2023-08-13 |
Not clear |
| Yeshwant Kurhe, Radhakrishnan Mahesh, Deepali Gupta, Thangaraj Devados. QCM-4, a serotonergic type 3 receptor modulator attenuates depression co-morbid with obesity in mice: an approach based on behavioral and biochemical investigations. European journal of pharmacology. vol 740. 2016-02-04. PMID:24973694. |
in conclusion, the results of the present study suggested that qcm-4 attenuated the depression co-morbid with obesity in mice subjected to cums which to some extent is mediated by reversing the "insulin resistance" or "altered plasma glucose" in obese mice. |
2016-02-04 |
2023-08-13 |
mouse |
| Annelies Brouwer, Daniël H van Raalte, Michaela Diamant, Femke Rutters, Eus J W van Someren, Frank J Snoek, Aartjan T F Beekman, Marijke A Bremme. Light therapy for better mood and insulin sensitivity in patients with major depression and type 2 diabetes: a randomised, double-blind, parallel-arm trial. BMC psychiatry. vol 15. 2016-01-26. PMID:26204994. |
light therapy for better mood and insulin sensitivity in patients with major depression and type 2 diabetes: a randomised, double-blind, parallel-arm trial. |
2016-01-26 |
2023-08-13 |
Not clear |
| Eleni A Greenwood, Lauri A Pasch, Kanade Shinkai, Marcelle I Cedars, Heather G Huddlesto. Putative role for insulin resistance in depression risk in polycystic ovary syndrome. Fertility and sterility. vol 104. issue 3. 2015-11-23. PMID:26054555. |
putative role for insulin resistance in depression risk in polycystic ovary syndrome. |
2015-11-23 |
2023-08-13 |
Not clear |
| Eleni A Greenwood, Lauri A Pasch, Kanade Shinkai, Marcelle I Cedars, Heather G Huddlesto. Putative role for insulin resistance in depression risk in polycystic ovary syndrome. Fertility and sterility. vol 104. issue 3. 2015-11-23. PMID:26054555. |
to evaluate whether insulin resistance is associated with depression risk in women with polycystic ovary syndrome (pcos), independent of other factors, including body mass index (bmi). |
2015-11-23 |
2023-08-13 |
Not clear |
| Phillip W Gold, Rodrigo Machado-Vieira, Maria G Pavlato. Clinical and biochemical manifestations of depression: relation to the neurobiology of stress. Neural plasticity. vol 2015. 2015-11-04. PMID:25878903. |
aspects such as depression subtypes, inflammation, insulin resistance, oxidative stress, and prothrombotic states in critical brain circuits and periphery are critically appraised. |
2015-11-04 |
2023-08-13 |
Not clear |